With increased exposure of patients to routine imaging, incidental benign intrathoracic masses are frequently recognized. Most have classical imaging features, which are pathognomonic for their benignity. The aim of this pictorial review is to educate the reader of radiological features of several types of intrathoracic masses. The masses are categorized based on their location/origin and are grouped into parenchymal, pleural, mediastinal, or bronchial. Thoracic wall masses that invade the thorax such as neurofi bromas and lipomas are included as they may mimic intrathoracic masses. All examples are illustrated and include pulmonary hamartoma, pleural fi broma, sarcoidosis, bronchial carcinoid, and bronchoceles together with a variety of mediastinal cysts on plain radiographs, computed tomography (CT) and magnetic resonance imaging (MRI). Sometimes a multimodality approach would be needed to confi rm the diagnosis in atypical cases. The study would include the incorporation of radionuclide studies and relevant discussion in a multidisciplinary setting.
I n this modern age of radiology practice, the advent of rapid scanners and quick scan turnover has meant that radiologists encounter a wide spectrum of pathologies.
In the case of thoracic imaging, for example, this would mean that the detection of pulmonary nodules (whether benign or malignant) on thinsection computed tomography (CT) examinations would have become an important part of the daily tasks of many radiologists -both thoracic and general radiologists. [1] CT has predominantly been the imaging technique of choice because certain CT features would help differentiate benign from malignant processes. [2] Diffi cult areas of interpretation would undoubtedly arise, for example, when assessing for pleural disease. The problem is of global signifi cance, which causes signifi cant morbidity and mortality. Complex imaging with CT, magnetic resonance imaging (MRI), and positron emission tomography-CT (PET-CT) are commonly utilized to allow accurate diagnosis through guided biopsies or even predict prognosis. [3] Lung carcinoma is obviously the biggest concern, and radiologists play an extremely important role in its detection on imaging. In the last decade, PET-CT has been increasingly employed to improve the assessment of patients with pulmonary nodules. The basis of this is that cells in a malignant tumor undergo glycolysis at an increased rate, and hence have a greater cellular uptake of glucose. [4, 5] The knowledge and ability to confidently interpret benign masses is critical to avoid further unnecessary tests. A number of features are reliable predictors of benignity. [6] High specifi city features of benign nodules include calcifi cation (diffuse, popcorn, central, and laminated), internal fat, polygonal (all surfaces concave or straight) unless in contact with a pleural surface, ovoid/ flat/tubular shaped and finally clustering of subcentimeter nodules in isolated lung segments.
In addition, a variety of systemic diseases may involve the thoracic structures and it is, therefore, critical for radiologists to be familiar with various patterns of abnormalities associated with them. Even when imaging fi ndings are nonspecifi c, the radiologist is often the fi rst to suggest the possibilities of diseases when confronted with a particular imaging pattern and supporting laboratory data. [7] However it should be noted that the role of imaging does have its limitations in certain scenarios. Take, for example, in the setting of a patient with rheumatoid arthritis and the development of pulmonary nodules. Rheumatoid nodules are a rare manifestation of lung disease associated with these arthritides, and their emergence and evolution can be variable. The diagnosis of rheumatoid nodules may therefore be suggested; but if these demonstrate atypical features, accurate diagnosis would still require a combination of baseline imaging, serial follow-up imaging, and even histological confi rmation. [8] The differential diagnoses, when considering a benign pulmonary mass, is wide, and the following [ Table 1 ] is presented for ease of categorization.
Lung Parenchyma Hamartoma
As the commonest benign tumor of the lung, pulmonary hamartomas are usually discovered incidentally, but some patients may have hemoptysis or cough. The peak incidence occurs during the 6 th decade. They are often detected late and demonstrate slow growth. [9] Constituting approximately 8% of all lung neoplasms, hamartoma is a tumor which contains cartilage, fat, fi brous tissue, and epithelial components. Malignant transformation is very rare and, therefore, hamartomas are left alone. [10] Characteristically fi ndings on CT include a lesion with a smooth edge, focal fat, or fat alternating with calcifi c foci (popcorn calcifi cation) [ Figures 1 and 2] .
Sarcoidosis
Sarcoidosis is a noncaseating, granulomatous, multisystem, chronic, infl ammatory condition of unknown etiology. Ninety percent of patients present with lung and mediastinal/hilar lymphadenopathy. [11] Often patients below the age of 40-years-old are affected and the incident peaks in the 3 rd decade of life. Up to half of patients remain asymptomatic, but symptoms would include respiratory complaints such as cough and dyspnea. [11] CT fi ndings of the chest include paratracheal, mediastinal, and bilateral hilar lymphadenopathy. [12] Pulmonary nodules, if present, would typically be in a peribronchovascular distribution or along fi ssures [ Figures 3 and 4 ]. Sarcoidosis can be staged even on the basis of chest radiographs [ Table 1 ]. [12] Progressive massive fi brosis (Pmf) PMF is also known as complicated silicosis, which develops through the expansion of individual silica nodules. Radiographic fi ndings include large symmetrical bilateral opacities of more than 1 cm, formed by nodule coalescence -typically like angel wings [ Figure 5 ]. CT will confi rm the presence of soft tissue masses, which have ill-defi ned margins and calcifi cations. [13] These opacities gradually migrate towards the hilum with evidence of emphysematous changes in the peripheries. The emphysema and volume loss aid the differentiation between unilateral PMF and lung cancer. PMF may be complicated by cavitation, ischemic necrosis, and concomitant tuberculous infection. [14] Intrapulmonary Lymph Node Intrapulmonary lymph nodes are commonly detected on CT examination of healthy individuals. Bankoff et al., were pioneers of an extensive research performed over a period of 15 years. They discovered that the distribution of intrapulmonary lymph nodes was predominantly in the lower half of the lungs due to larger ventilation and lymphatic fl uid production. [15] It is now known that these lymph nodes tend to be oval and occur within a lymphatic distribution subpleurally. They measure approximately 6 mm and can have sharply defi ned triangular borders [ Figure 6 ]. The nodules are homogeneous and do not calcify. [16] Rheumatoid nodules The thoracic manifestations of rheumatoid arthritis would include pleural diseases, rheumatoid nodules, diffuse interstitial pneumonia, pulmonary vasculitis, and airway disease. The commonest CT finding according to Tanaka et al., was ground glass opacification at 90%. Nodules were observed in 50% of patients and were mostly in the centrilobular distribution. These nodes were thought to arise from antigenic stimuli, for example, from dust inhalation. [17] Figures 7 and 8 are examples of benign rheumatoid nodules.
Pulmonary infarct
Chronic left heart failure and pulmonary embolism are recognized as important causes of pulmonary infarction. The latter can occur despite the dual blood supply to the lungs and the protective effect of the bronchial vasculature. In particular, infarction occurs commonly when vessels less than 3 mm in diameter are occluded. [18, 19] Typical radiographic features include wedge-shaped, pleuralbased opacifi cation with no evidence of air bronchograms [ Figure 9 ]. The latter usually occurs in areas of reduced lung attenuation. If there has been recent hemorrhage, the mass will demonstrate a convex border with a halo sign. [18] [19, 20] Wegener's granulomatosis Described by Friedrich Wegener, a German pathologist, Wegener granulomatosis is an uncommon disorder, which manifests as chronic granulomatous necrotizing vasculitis involving small-to medium-sized vessels. It is one of the antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides, which affects many organ systems with 90% pulmonary and 80% renal involvement. Classically, patients would present with sinusitis, cough, hemoptysis, and glomerulonephritis. [21] Lung nodules are the commonest manifestation of Wegner's, and these are multiple and bilateral with no zonal predilection. These measures usually between 2 and 4 cm, and approximately a quarter of those larger than 2 cm may show thin/thick and nodular cavitation [ Figure 13 ]. Wegener's can easily mimic tuberculosis, metastases, lung abscesses, or septic infarcts. If hemorrhage has occurred around nodules, this will manifest as a halo sign, whereby there is ground-glass opacity surrounding a consolidated nodule. Correlation with cytoplasmic antineutrophil cytoplasmic antibodies (c-ANCA) levels may help with the diagnosis. [22] Pleural Fibroma First described in 1931, localized or solitary fi brous tumor of the pleura (LFTP) is a rare and slow-growing neoplasm. They are usually discovered incidentally on chest radiographs of asymptomatic individuals. There is no gender predilection or association with prior asbestos exposure. Symptoms would be nonspecifi c and include cough, dyspnea, chest pain, and hypertrophic pulmonary osteoarthropathy. [11] LFTPs can be rounded, oblong, or lobulated. They are often found in the dependent portions of the thorax, and if large, they will displace rather than invade adjacent structures [ Figure 14 ]. On unenhanced CT, LFTP would be of soft-tissue attenuation and MR would show intermediate to low signal on T1 and also T2 hypointensity [ Figure 15 ]. Marked enhancement is demonstrated with contrast because of rich vascular supply. There might be associated cysts and hemorrhagic necrosis. Surgical excision is usually curative with a 16% risk of local (1), also elegantly shown by gas within the soft tissues of the foot on ultrasound examination. There are multiple pleural-based nodules on the CXR suggestive of septic emboli (3) Figure 11 : Axial CT images from the same patient as in Figure 10 with a gas gangrene of the foot showing multiple, pleural-based nodules due to septic emboli with evidence of early cavitation in one of the nodules (arrow) Figure 12 : CXR showing a thick-walled cavity with an air-fl uid level due to a cavitating pulmonary infarct. The cavity is indistinguishable from other cavities such as cavitating neoplasia. To achieve a diagnosis, the history and the radiological evolution is important. This patient was a known pulmonary infarct, which subsequently cavitated recurrence. [23] Fibroma mimics, would include mesothelioma, pleural lipoma, pleural fi brosarcoma, or intercostal nerve neurilemoma (schwannoma). [23] Splenosis Intrathoracic splenosis is rare and involves autotransplantation of splenic tissue into the pleural cavity, commonly secondary to diaphragmatic and splenic rupture following blunt or penetrating abdominal trauma [ Figure 16 ]. Thourani et al., described the chest radiographic fi ndings of a pleural-based mass (confi rmed on CT). Surgically they observed numerous purplish implants throughout the thoracic cavity which covered the pleural, pericardial, and hemidiaphragmatic surfaces. The presence of Howell-Jolly bodies on postoperative blood smear confirmed the diagnosis of intrathoracic splenosis. [24] Intrathoracic splenosis is usually a benign condition, in comparison to abdominal splenosis whereby patients may present with pain and bowel obstruction. Imaging diagnosis can be made by technetium 99m Tc-labeled heat-damaged erythrocyte scan, 99mTc sulfur colloid scintigraphy, or indium 111 In-labeled platelet scan [ Figure 17 ]. [24, 25] Pleural Plaques Pleural plaques are the commonest manifestation of asbestos exposure, which usually arise from the parietal pleura, but can also involve visceral pleura [ Figure 18 ]. There is usually a latency period of 20-30 years. Classically, pleural plaques on chest radiographs are seen along the posterolateral chest wall and features are pathognomonic when seen along the dome of the diaphragm. The costophrenic angles and apices are usually spared. Calcifi cation of these plaques occurs in 10-15% of case. [26, 27] Asbestosis rarely occurs in the absence of pleural plaques. In fact, pleural effusion is the earliest manifestation of previous asbestos exposure and this usually has a latency period of 10 years. [27] Loculated Pleural Effusion Feldman in 1951 has described localized interlobar pleural effusion as a reversible entity and typically occurred during congestive heart failure. The effusion can either clear spontaneously or with treatment response. The disease thought to provoke this response was termed obliterative pleuritis. [28] A loculated interlobular pleural effusion or pulmonary pseudotumor is a term frequently used to describe focal fl uid collections trapped in the pleural fi ssures. Particularly on chest radiographs, these entities can cause confusion and appear as a solid pulmonary mass [ Figures 19 and 20] . The opacities are typically elongated along the direction of the fi ssures and may have tapered ends. A lateral chest radiograph is often useful for further characterization these masses. In equivocal cases, CT would help establish the fl uid density of the apparent mass and its location within a minor or major fi ssure[ Figure 19 ]. [29] These vanishing tumors are often seen in patients presenting with congestive cardiac failure. As the patient's disease begins to improve, radiological features would sometimes lag and the resorption of the interlobar pleural fl uid would be slower to show resolution than the other signs of cardiac failure. An eventual chest radiograph would however show resolution of the fl uid. [28] [29] [30] Rounded Atelectasis Round atelectasis may mimic a pulmonary mass lesion. It is an unusual form of lung collapse or folded lung, which lies adjacent to the pleural surface. Hanke and Kretzschmar coined the term round atelectasis, and this entity affect predominantly male patients and those with prior asbestos exposure. [31] It is almost always asymptomatic and is typically detected incidentally on chest radiographs. [32] Characteristically, round atelectasis demonstrate the comet tail sign. Commonly seen in the posterior aspect of a lower lobe, bronchi and vessels curve into an apparent mass at its hilar pole-this feature is important to recognize. The adjacent pleural thickening is an essential feature [ Figure 21 ]. The affected lobe would demonstrate volume loss and the mass may have air bronchograms. [32, 33] No specifi c treatment is required for round atelectasis. They will be slow growing, remain stable, or spontaneously disappear. Fine-needle aspiration biopsy is however required in equivocal cases, to distinguish this entity from bronchogenic carcinomas. [32] Pleural Lipoma The commonest benign soft tissue of the pleura is a pleural lipoma. These soft, fatty, and encapsulated tumors are slow growing and originate from the submesothelial layers of the parietal pleura and may extend into the subpleural/pleural/ extrapleural space [ Figure 22 ]. They can become extremely large. Patients would often remain asymptomatic or present with nonproductive cough, exertional dyspnea, chest heaviness, or back pain. Radiographic features include fat attenuation and homogeneity on CT (approximately HU-100). [10] Molinari et al., describes the importance of differentiation of a pleural lipoma from a liposarcoma. Liposarcomas may arise in all thoracic regions which contain adipose tissue. The inhomogeneity of these tumors on either CT or MRI helps differentiate liposarcomas from lipomas. Irregular areas of enhancing soft tissue would also suggest a malignant nature. If in doubt, 18-fl uorodeoxygenase positron emission tomography (18-FDG-PET) may be valuable in the differentiation of lipomas from liposarcomas. [34] Bronchial Carcinoid These are uncommon pulmonary neoplasms of neuroendocrine origin. Approximately 75% of bronchial carcinoid tumors arise in the lobar bronchi, 10% occur in the main-stem bronchi, and 15% originates in the periphery of the lung. They secrete a variety of chemical substances, but association with carcinoid syndrome is very rare. Occasionally, Cushing's syndrome due to ectopic hormone production is caused by bronchial carcinoid tumors. [35] Seventy-five percent of bronchial carcinoids are detected on conventional chest radiographs with smaller ones only seen on CT. [35] Radiologic fi ndings are usually related to bronchial obstruction. Central bronchial carcinoids manifest as a well-defi ned endobronchial nodule, hilar or a perihilar mass closely related to the bronchial tree. Associated atelectasis, air trapping, obstructing pneumonitis, and mucoid impaction may also be seen. Peripheral bronchial carcinoids appear as solitary nodules [ Figure 23 ]. Calcifi cation is common and is easily visualized at CT. [36] Prognosis of bronchial carcinoids is highly dependent on histologic fi ndings and stage of the tumor: Typical bronchial carcinoids have an excellent prognosis, whereas atypical bronchial carcinoids have a worse prognosis. [35, 36] Pulmonary resection is the treatment of choice for bronchial carcinoids. [36] Bronchogenic cysts Is a rare congenital malformation of the bronchial tree; however, it is considered the commonest of foregut duplication cysts. It accounts for 5-10% of pediatric mediastinal masses. Most bronchogenic cysts are asymptomatic and found incidentally on imaging. However, mediastinal cysts can present as a mediastinal mass that may enlarge and cause local compression and respiratory distress. Infection of bronchogenic cysts is also reported. [37] Bronchogenic cyst forms as an abnormal budding of the bronchial tree during embryogenesis that is lined by secretory respiratory epithelium (cuboid or columnar ciliated epithelium). The wall is made up of tissues similar to that of the normal bronchial tree, including cartilage, elastic tissues, mucous glands, and smooth muscle. They contain water, variable amounts of proteinaceous material, blood products, and calcium oxalate; and hence can be confused with solid lesions due to their high attenuation content. They do not usually communicate with the bronchial tree and therefore typically are nonaerated. Occasionally a communication may develop following infection or intervention, resulting in and air-fi lled cystic structure with an air-fl uid level. [38] Bronchogenic cysts can be classified as mediastinal and intrapulmonary types. The most common location is the middle mediastinum (65-90%). Parenchymal (intrapulmonary) bronchogenic cysts are typically perihilar with lower lobes predilection. [37] On plain radiographs, the cysts usually appear as soft-tissue density rounded structures, sometimes with compression effect of surrounding structures. On CT, they appear as wellcircumscribed spherical or ovoid masses of variable attenuation as discussed above.
Approximately 50% are fl uid density (0-20 HU), with the remaining cysts being of soft tissue density (>30 HU) or even hyperdense compared to the mediastinal soft tissue. CT can also detect calcium oxalate (milk of calcium) layering dependently. No solid contrast enhancement is the general rule [ Figures 24 and 25] . [38] Treatment options include surgical excision of the cyst considering the chance of developing complications like infection, hemorrhage, bronchial obstruction, and rarely, to undergo malignant transformation. Increasingly, these lesions are treated with transbronchial or percutaneous CT-guided aspiration that will confi rm the diagnosis and treat/reduce their size. Small lesions can be followed, however, they do have a tendency to increase in size over time, sometimes rapidly. [38] Malignant transformation is very rare, but reported, with primaries including: Rhabdomyosarcoma, pleuropulmonary blastoma, anaplastic carcinoma, leiomyosarcoma, and adenocarcinoma. [39] Bronchocele Bronchocele (bronchial mucocele) refers to a mucous-fi lled and dilated bronchus surrounded by aerated lung. [40] These can be the result of an obstructive lesion to the bronchial tree as in congenital bronchial atresia where they usually affect the apicoposterior segment of the left upper lobe. Other obstructive causes include benign or malignant bronchial neoplasms, bronchogenic cysts, and foreign bodies. Nonobstructive bronchoceles are usually seen in asthmatic patients due to increased mucous production. [41] Asthmatic patients are also predisposed to Aspergillus infection and, therefore, allergic bronchopulmonary aspergillosis (ABPA) can result in bronchocele with a characteristic branching pattern. Cystic fi brosis is also a reported cause of nonobstructive bronchoceles due to impaired ciliary movement and thick secretions. [42] Bronchoceles can be diffi cult to diagnose on plain radiographs as their branching tubular opacity can be diffi cult to differentiate from the normal vascular pattern. CT would better defi ne a tubular and branching intrapulmonary opacity that is distinct from vascular shadows [ Figures 26 and 27 ]. Their appearance is sometimes described as a typical "finger in glove". CT attenuation of the mucus can be high in ABPA. [42] The typical appearance for a bronchocoele resulting from bronchial atresia occurs immediately distal to the expected location of the apical segmental bronchus, where there will be a hyperlucent segment or lobe distal to the bronchocele owing to collateral air drift. [41] Mediastinal Hydatid cyst Hydatid cyst disease results from infection by the larval stage of the dog tapeworm Echinococcosis granulosus. The lung is the second most common site of involvement with Echinococcosis granulosus in adults after the liver. Thoracic involvement may occur by transdiaphragmatic route in cases of hepatic disease or via hematogenous spread. [43] Chest radiographs and CT are the most widely used modalities to image thoracic hydatid disease. Chest CT features include multiple or solitary cystic lesion [ Figure 28 ]. Size can be variable, ranging between 1 and 20 cm and usually demonstrate lower lobes predilection. Air crescent sign and fl oating membranes (water lily sign) are described in cases of hydatid cyst ruptures. [44] Surgery remains the mainstay of treatment. Less invasive methods and combinations with chemotherapy are being developed.
Goiter
Enlargement of the thyroid gland is one of the causes of superior mediastinal mass [ Figures 29 and 30 ]. Although there is no clear defi nition, but thyroid gland enlargement is considered as a goiter that requires surgical removal when there is retrosternal extension with intrathoracic component appears to extend more than 3 cm from the thoracic inlet [ Figure 31 ]. [45] Ultrasound with Doppler studies is the imaging modality of choice when there is clinical suspicion of enlarged thyroid gland. The latter modality usually demonstrates diffuse enlargement/nodularity of the gland with possible colloid content. It is also useful to evaluate retrosternal extension. CT can evaluate the degree of intrathoracic extension in larger goiters. They usually demonstrate contrast enhancement and may contain calcifi cation.
Pericardial cyst
These are uncommon congenital cysts of the anterior and middle mediastinum that result from abnormalities in the development of the coelomic cavities. Rarely can they occur as a result of previous pericarditis. [46] Most cases are diagnosed incidentally on imaging and remain asymptomatic.
Pericardial cysts are typically seen as right cardiophrenic angle mass, but can be found anywhere adjacent to the heart [ Figure 32 ]. On CT, they appear as well-defi ned, nonenhancing, low (water) attenuating, rounded mass next to the pericardium. MR examination usually shows typical fl uid signal content with occasional high signal on T1-weighted images due to proteinaceous material and there is no enhancement with intravenous contrast on CT or MR [ Figure 33 ]. [47] Thymoma Thymoma is a rare mediastinal neoplasm, but is the most common primary neoplasm of the anterior mediastinum. [48] They typically present in the 5 th -6 th decades, without gender predilection. Presentation is usually secondary to mass effect within the anterior mediastinum (venous obstruction, dysphagia, or breathing diffi culties secondary to airway's compression). It has strong association with myasthenia gravis, 10-20% of patients with myasthenia gravis have a thymoma, 30-50% of patients with a thymoma have myasthenia gravis. Other associations include pure red cell aplasia, hypogammaglobulinemia, systemic lupus erythematosus (SLE), rheumatoid arthritis, and non-thymic cancers. Thymomas can be divided into invasive and noninvasive ones. The latter tend to be noncapsulated and may show pleural seeding at time of diagnosis. They are usually unresectable and with poor prognosis. [49] Plain fi lms will show a well-defi ned, lobulated anterior mediastinal mass which can demonstrate associated calcifi cation. CT will show soft tissue attenuation masses usually seen between the sternum and great vessels [ Figures 34-36] . Mediastinal lymph node enlargement may be present (13-44%). [50] Thymic hyperplasia Thymic hyperplasia refers to hyperplasia of the thymus gland. The latter is important to differentiate from thymic neoplasms. Diffuse and symmetric enlargement of the gland is the most common radiological fi nding differentiating it from neoplasms, which tend to manifest as focal masses [ Figure 36 ]. Both thymic hyperplasia and malignancy can demonstrate increased activity on FDG-PET because the thymus demonstrates normal physiologic uptake and, therefore, differentiation between the two is diffi cult. [51] Pathologically, thymic hyperplasia can be divided into two forms. These cannot be differentiated on the basis of imaging: i-True thymic hyperplasia: This is usually associated with chemotherapy, radiotherapy, and systemic stresses; and ii-lymphoid hyperplasia which is usually associated with myasthenia gravis, SLE, rheumatoid arthritis, scleroderma, and Graves' disease. [52] Thymic cyst Thymic cysts can be seen in cervical or mediastinal regions. They are usually divided into:
Congenital -often unilocular or acquired -often multilocular and can happen secondary to thoracotomy, chemotherapy, or radiotherapy for mediastinal malignancy or secondary to inflammation. [53] On CT, thymic cysts can be lobulated and may demonstrate soft-tissue attenuation components. They usually show typical cystic signal characteristic on MR without intrinsic enhancement [ Figures 37-39] . [54] Schwannoma Benign nerve sheath tumors are usually seen as posterior mediastinal or paraspinal masses. On CT, schwannomas are frequently heterogeneous with areas of low attenuation secondary to cystic degeneration, hypercellularity, hemorrhage, lipid, or myelin. Punctate calcifi cations may also be detected on CT [ Figure 40 ]. Enhancement pattern can be variable (homogeneous, heterogeneous, or peripheral). They may extend through the adjacent intervertebral foramen to the spinal canal with a "dumb-bell" confi guration. MRI typically exhibits low-tointermediate signal intensity on T1-weighted imaging and may show areas of intermediate-to-high signal intensity on T2-weighted imaging. [55] Extramedullary Hematopoiesis Extramedullary hematopoiesis is a response to erythropoiesis failure in bone marrow. Therefore, this disease can be seen in hemoglobinopathies, myeloproliferative disorders, or bone marrow infi ltration. It tends to affect spleen and liver and occasionally in the lymph nodes. Less common organs include the pleura, lungs, gastrointestinal tract, and kidneys. [55] Radiological manifestation of thoracic disease usually includes paraspinal masses (usually bilateral) with rounded and lobulated margins. Medullary expansion of the bony structures with trabeculae resorption can be seen [ Figure 41 ]. These masses do not calcify or cause bone erosion. They tend to show low attenuation on CT with mild contrast enhancement. Other less common thoracic manifestation of the disease includes interstitial pulmonary abnormality, pleural mass, or hemothorax. Spleen can be enlarged or absent. Diagnosis can be confi rmed with percutaneous fi ne-needle aspiration or biopsy. Usually this condition regresses with treating the underlying cause. [55] Chronic Calcifi c Hematoma Kidner in 1917 noted that calcifi ed hematoma would occur secondary to trauma. [56] He proposed that pathologically, deep muscle fi bers would tear after any trauma, and a break in the periosteum would occur at the same time. The resulting hemorrhage would form a mass in the deepest layer of tissue. A fi brous tissue membrane would later form to prepare for blood clot absorption. Eventually, there is calcium deposition.
In the current radiological context, a thoracic chronic expanding hematoma (CEH) presents clinically as a slowly growing mass months or years after the initial injury. Calcifi ed hematomas may grow to a very large size occupying the entire hemithorax with distortion of the mediastinum [ Figure 42 ]. Patients at this stage may present with respiratory distress. [57] Pathologically, the calcifi ed mass will contain central mass of blood and a wall of granulation tissue, which is dense along the periphery. A CT-guided needle biopsy can be performed to exclude infectious or neoplastic cells. There, however, needs to be care in the diagnostic process due to risk of massive bleeding. Total surgical removal would be the treatment of choice. [57, 58] 
Conclusion
The overall importance of good radiology detection and clinical judgment cannot be underestimated. If not, there can be implications of misdiagnosis and unnecessary further investigations, which will in turn carry the risk of radiation burden and can, lead to invasive procedures like biopsies. Furthermore there is signifi cant impact on departmental resources and fi nancial costs.
Finally, with reference to this review, good clinicoradiological understanding of benign entities would ensure smooth communication of fi ndings to clinicians and most importantly allay patient worries. Note the paravertebral location of the extramedullary hematopoiesis
